This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders | MicrobiomeTrials
← Back to trials NCT06081348
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-09-16Est. Completion: 2027-09
Enrollment target: 130 participantsLocations Alberta Children's Hospital - University of Calgary, Calgary, Alberta, Canada University of Alberta-Glenrose, Edmonton, Alberta, Canada Dalhousie University - IWK Health Centre, Halifax, Nova Scotia, Canada McMaster University, Hamilton, Ontario, Canada Queen's University, Kingston, Ontario, Canada University of Western Ontario, Lawson Health Research Institute, London, Ontario, Canada Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada Other microbiome trials you might be interested in Obsessive - Compulsive Disorder Tic Disorder, Chronic Motor or Vocal Tic Disorders Tic Disorder, Combined Vocal and Multiple Motor Tourette Disease Tourette Disorder Tourettes Syndrome Gilles de la Tourette Syndrome
Obsessive-Compulsive Disorder and Tic Disorders frequently co-occur, and a subgroup of patients - those with a Tourettic…
London, United Kingdom Est. completion Aug 1, 2027
Autism Spectrum Disorder Food Selectivity
The goal of this randomized, single-blind clinical trial is to evaluate the effectiveness of the Exploradores de Sabores…
Tijuana, Mexico Est. completion Dec 2026
Autism Spectrum Disorder (ASD)
The goal of this sequential multiple assignment randomized trial is to conduct a preliminary evaluation of Our Love, Our…
Seoul, South Korea Est. completion Mar 31, 2028